Arthritis - TODAYshow.com

FDA reviewing arthritis drugs for cancer link

The FDA is investigating whether a group of best-selling arthritis drugs made by Abbott Laboratories, Schering-Plough Corp. and other companies heighten the risk of cancer in youngsters. Full story

Breast-feeding may cut mom's arthritis risk

Half of U.S. diabetics also have arthritis

Arthritis pill may cut heart attack risk

Glucosamine fails to ease hip arthritis

Gene therapy trial to resume after patient death

More arthritis stories

Many arthritic adults suffer work limitations

N.J. rejects Vioxx class-action suit

FDA rejects successor to Vioxx

FDA advisers reject Vioxx successor

Arthritis supplements often come up short

FDA panel doubts safety of Vioxx successor

Exercise can prevent arthritis in women

Arthritis conditions cost U.S. billions

FDA OKs Celebrex for kids with arthritis